Peripherally acting µ-opioid receptor antagonist
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Peripherally acting µ-opioid receptor antagonist, covering 2024-03-21 to 2024-03-21. Get the full timeline:
Most recent: Clinical Trial Update: Effects of a Peripherally Acting µ-opioid Receptor Antagonist on Recurrent Acute Pancreatitis [Phase 2, Phase 3]